Tianjin Historical Income Statement

600488 Stock

4.54 0.09 2.02%

Historical analysis of Tianjin Tianyao income statement accounts such as Selling General Administrative of 1.2 B, Total Revenue of 4 B or Operating Income of 157.1 M can show how well Tianjin Tianyao Pharmaceuticals performed in making a profits. Evaluating Tianjin Tianyao income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Tianjin Tianyao's future profits or losses.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Tianjin Tianyao Phar latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Tianjin Tianyao Phar is a good buy for the upcoming year.

Net Income Gross Profit

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Tianjin Tianyao Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

About Tianjin Income Statement Analysis

Tianjin Tianyao Phar Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Tianjin Tianyao shareholders. The income statement also shows Tianjin investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Tianjin Tianyao Income Statement Chart

At present, Tianjin Tianyao's Interest Expense is projected to increase significantly based on the last few years of reporting. The current year's Selling General Administrative is expected to grow to about 1.2 B, whereas Operating Income is forecasted to decline to about 157.1 M.

Selling General Administrative Total Revenue Operating Income Cost Of Revenue Income Tax Expense Net Income From Continuing Ops

Total Revenue

Total revenue comprises all receipts Tianjin Tianyao Phar generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Operating Income

Operating Income is the amount of profit realized from Tianjin Tianyao Phar operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Tianjin Tianyao Pharmaceuticals is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.

Cost Of Revenue

Cost of Revenue is found on Tianjin Tianyao Phar income statement and represents the costs associated with goods and services Tianjin Tianyao provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Most accounts from Tianjin Tianyao's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Tianjin Tianyao Phar current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Tianjin Tianyao Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

	2021	2022	2023	2024 (projected)
Operating Income	239.2M	246.9M	244.3M	157.1M
Total Revenue	3.7B	3.7B	3.8B	4.0B

Operating Income Total Revenue

Tianjin Tianyao income statement Correlations

	Selling General Administrative	Total Revenue	Operating Income	Cost Of Revenue	Income Before Tax	Net Income	Income Tax Expense	Minority Interest	Research Development	Gross Profit	Other Operating Expenses	Net Income From Continuing Ops	Ebit	Total Operating Expenses	Total Other Income Expense Net	Tax Provision	Net Interest Income	Interest Income	Ebitda	Reconciled Depreciation
Selling General Administrative		0.98	0.75	0.75	0.23	-0.07	0.03	0.0	0.93	0.97	0.84	0.2	0.68	0.98	-0.93	0.29	-0.92	-0.78	0.75	0.91
Total Revenue	0.98		0.73	0.8	0.26	-0.01	0.02	0.01	0.91	0.94	0.82	0.22	0.68	0.95	-0.89	0.29	-0.89	-0.76	0.75	0.89
Operating Income	0.75	0.73		0.64	0.68	0.42	0.48	0.36	0.81	0.85	0.74	0.63	0.86	0.76	-0.88	0.67	-0.7	-0.59	0.71	0.55
Cost Of Revenue	0.75	0.8	0.64		0.19	-0.08	0.1	0.04	0.79	0.79	0.71	0.15	0.46	0.82	-0.67	0.27	-0.75	-0.61	0.48	0.77
Income Before Tax	0.23	0.26	0.68	0.19		0.84	0.69	0.43	0.36	0.34	0.33	0.96	0.7	0.22	-0.44	0.8	-0.14	-0.16	0.64	-0.03
Net Income	-0.07	-0.01	0.42	-0.08	0.84		0.37	0.22	0.06	0.02	0.16	0.85	0.48	-0.1	-0.12	0.43	0.24	0.28	0.31	-0.23
Income Tax Expense	0.03	0.02	0.48	0.1	0.69	0.37		0.67	0.14	0.17	0.05	0.54	0.53	0.06	-0.28	0.94	-0.22	-0.4	0.5	-0.23
Minority Interest	0.0	0.01	0.36	0.04	0.43	0.22	0.67		0.16	0.14	0.01	0.36	0.56	0.0	-0.28	0.63	-0.14	-0.27	0.21	-0.16
Research Development	0.93	0.91	0.81	0.79	0.36	0.06	0.14	0.16		0.96	0.81	0.34	0.73	0.95	-0.9	0.4	-0.87	-0.74	0.71	0.86
Gross Profit	0.97	0.94	0.85	0.79	0.34	0.02	0.17	0.14	0.96		0.88	0.31	0.76	0.98	-0.96	0.42	-0.92	-0.77	0.75	0.88
Other Operating Expenses	0.84	0.82	0.74	0.71	0.33	0.16	0.05	0.01	0.81	0.88		0.37	0.73	0.86	-0.81	0.26	-0.72	-0.5	0.67	0.82
Net Income From Continuing Ops	0.2	0.22	0.63	0.15	0.96	0.85	0.54	0.36	0.34	0.31	0.37		0.67	0.2	-0.4	0.69	-0.05	0.0	0.55	-0.02
Ebit	0.68	0.68	0.86	0.46	0.7	0.48	0.53	0.56	0.73	0.76	0.73	0.67		0.64	-0.84	0.71	-0.63	-0.57	0.82	0.46
Total Operating Expenses	0.98	0.95	0.76	0.82	0.22	-0.1	0.06	0.0	0.95	0.98	0.86	0.2	0.64		-0.9	0.3	-0.93	-0.78	0.7	0.94
Total Other Income Expense Net	-0.93	-0.89	-0.88	-0.67	-0.44	-0.12	-0.28	-0.28	-0.9	-0.96	-0.81	-0.4	-0.84	-0.9		-0.51	0.88	0.75	-0.81	-0.75
Tax Provision	0.29	0.29	0.67	0.27	0.8	0.43	0.94	0.63	0.4	0.42	0.26	0.69	0.71	0.3	-0.51		-0.41	-0.54	0.7	0.0
Net Interest Income	-0.92	-0.89	-0.7	-0.75	-0.14	0.24	-0.22	-0.14	-0.87	-0.92	-0.72	-0.05	-0.63	-0.93	0.88	-0.41		0.94	-0.74	-0.85
Interest Income	-0.78	-0.76	-0.59	-0.61	-0.16	0.28	-0.4	-0.27	-0.74	-0.77	-0.5	0.0	-0.57	-0.78	0.75	-0.54	0.94		-0.73	-0.66
Ebitda	0.75	0.75	0.71	0.48	0.64	0.31	0.5	0.21	0.71	0.75	0.67	0.55	0.82	0.7	-0.81	0.7	-0.74	-0.73		0.53
Reconciled Depreciation	0.91	0.89	0.55	0.77	-0.03	-0.23	-0.23	-0.16	0.86	0.88	0.82	-0.02	0.46	0.94	-0.75	0.0	-0.85	-0.66	0.53

Click cells to compare fundamentals

Tianjin Tianyao Account Relationship Matchups

Tianjin Tianyao income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Interest Expense	36.7M	40.2M	45.9M	48.2M	36.7M	38.5M
Selling General Administrative	765.7M	919.9M	1.2B	1.2B	1.1B	1.2B
Total Revenue	2.9B	3.1B	3.7B	3.7B	3.8B	4.0B
Operating Income	306.7M	223.1M	239.2M	246.9M	244.3M	157.1M
Cost Of Revenue	1.5B	1.7B	2.0B	1.9B	2.0B	1.1B
Income Before Tax	253.0M	112.4M	149.1M	12.5M	168.2M	117.9M
Net Income Applicable To Common Shares	145.2M	161.8M	34.0M	35.4M	40.7M	38.7M
Net Income	145.3M	34.0M	48.7M	35.4M	117.1M	87.9M
Income Tax Expense	76.3M	31.8M	40.4M	(5.9M)	(6.8M)	(6.5M)
Minority Interest	755.6M	781.1M	(60.0M)	17.0M	(45.6M)	(43.3M)
Research Development	129.4M	138.1M	133.3M	142.7M	161.1M	117.7M
Gross Profit	1.4B	1.4B	1.8B	1.8B	1.8B	1.3B
Other Operating Expenses	32.6M	31.5M	18.8M	40.2M	46.2M	29.2M
Net Income From Continuing Ops	183.2M	80.6M	108.7M	18.4M	162.7M	93.8M
Ebit	322.8M	178.0M	178.2M	181.3M	208.4M	210.5M
Total Operating Expenses	2.6B	2.9B	3.5B	3.4B	3.5B	2.7B
Tax Provision	69.8M	31.8M	40.4M	(5.9M)	5.6M	5.3M
Net Interest Income	(37.2M)	(41.1M)	(46.6M)	(45.5M)	(29.0M)	(30.5M)
Interest Income	2.3M	2.3M	2.1M	4.4M	8.6M	5.2M
Ebitda	432.5M	336.3M	403.7M	317.8M	365.4M	394.4M
Reconciled Depreciation	142.8M	183.7M	208.8M	257.1M	271.1M	199.9M

Currently Active Assets on Macroaxis

ESRT	Empire State Realty
C	Citigroup
C	Citigroup
GOOG	Alphabet Inc Class C
DD	Dupont De Nemours

Other Information on Investing in Tianjin Stock

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Tianjin Historical Income Statement

About Tianjin Income Statement Analysis

Tianjin Tianyao Income Statement Chart

Total Revenue

Operating Income

Cost Of Revenue

Tianjin Tianyao income statement Correlations

Tianjin Tianyao Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Tianjin Tianyao income statement Accounts

Currently Active Assets on Macroaxis

Other Information on Investing in Tianjin Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Revenue	+ 0.98	Selling General Administrative
Total Operating Expenses	+ 0.98	Selling General Administrative
Total Operating Expenses	+ 0.98	Gross Profit
Gross Profit	+ 0.97	Selling General Administrative
Net Income From Continuing Ops	+ 0.96	Income Before Tax
Gross Profit	+ 0.96	Research Development

Total Other Income Expense Net	- 0.96	Gross Profit
Net Interest Income	- 0.93	Total Operating Expenses
Total Other Income Expense Net	- 0.93	Selling General Administrative
Net Interest Income	- 0.92	Gross Profit
Net Interest Income	- 0.92	Selling General Administrative
Total Other Income Expense Net	- 0.9	Total Operating Expenses